WITTENBERG INVESTMENT MANAGEMENT, INC. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 39 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
WITTENBERG INVESTMENT MANAGEMENT, INC. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,586
+2.6%
209,739
+2.3%
0.95%
+3.9%
Q2 2023$2,521
+3.6%
204,994
+3.5%
0.91%
+0.7%
Q1 2023$2,433
+11.0%
197,994
+3.6%
0.91%
+1.6%
Q4 2022$2,191
-99.7%
191,194
+1.3%
0.89%
+196.3%
Q3 2022$708,000
-37.0%
188,6940.0%0.30%
-36.6%
Q2 2022$1,123,000
-5.9%
188,6940.0%0.48%
+5.6%
Q1 2022$1,193,000
+61.7%
188,6940.0%0.45%
+67.9%
Q4 2021$738,000
-19.0%
188,6940.0%0.27%
-23.4%
Q3 2021$911,000
-24.7%
188,694
-0.3%
0.35%
-28.3%
Q2 2021$1,210,000
+3.5%
189,294
+1.7%
0.49%
-9.1%
Q1 2021$1,169,000
-8.9%
186,1980.0%0.54%
-14.2%
Q4 2020$1,283,000
+106.9%
186,1980.0%0.63%
+88.0%
Q3 2020$620,0000.0%186,1980.0%0.33%
-3.8%
Q2 2020$620,000
+55.0%
186,1980.0%0.35%
+58.0%
Q1 2020$400,000
-31.9%
186,1980.0%0.22%
-3.9%
Q4 2019$587,000
-29.4%
186,198
+0.6%
0.23%
-37.0%
Q3 2019$831,000
-28.4%
185,118
-3.4%
0.36%
-26.9%
Q2 2019$1,160,000
-22.8%
191,729
-11.3%
0.50%
-22.2%
Q1 2019$1,502,000
+74.9%
216,118
-2.9%
0.64%
+57.4%
Q4 2018$859,000
-36.7%
222,467
-12.7%
0.40%
-27.3%
Q3 2018$1,358,000
+9.0%
254,752
+0.4%
0.56%
+5.7%
Q2 2018$1,246,000
+25.5%
253,752
+105.8%
0.53%
+23.2%
Q1 2018$993,000
+15.6%
123,311
+47.1%
0.43%
+14.2%
Q4 2017$859,000
-9.1%
83,811
+28.9%
0.37%
-7.9%
Q3 2017$945,00065,0180.41%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
22NW, LP 749,302$2,892,0001.80%
Clearline Capital LP 316,425$1,221,0000.84%
Newtyn Management, LLC 888,620$3,430,0000.67%
Western Standard LLC 150,363$580,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 222,467$859,0000.40%
BVF INC/IL 721,935$2,787,0000.36%
Sepio Capital, LP 411,676$1,589,0000.12%
Yakira Capital Management, Inc. 66,934$258,0000.09%
J. Goldman & Co LP 152,095$587,0000.04%
Spark Investment Management LLC 48,909$188,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders